<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>267999</rcn>
  <id>101159996</id>
  <acronym>IMPROVE-HPV</acronym>
  <teaser>Cervical cancer, caused by human papillomavirus (HPV), is almost entirely preventable through prophylactic HPV vaccination. Many countries have yet to implement HPV vaccination programmes or are struggling to achieve high vaccine coverage. This presents a major challenge for...</teaser>
  <objective>Cervical cancer, caused by human papillomavirus (HPV), is almost entirely preventable through prophylactic HPV vaccination. Many countries have yet to implement HPV vaccination programmes or are struggling to achieve high vaccine coverage. This presents a major challenge for meeting the World Health Organisation (WHO) cervical cancer elimination target, with 90% of 15 year-old girls being vaccinated against HPV by 2030. Originally licenced as multidose vaccines, WHO has recently recommended that countries can offer a single HPV vaccine dose to 9-20 year olds. The IMPROVE-HPV consortium, a partnership of research institutions in Tanzania, Nigeria, UK and Spain, will investigate barriers to HPV vaccine uptake and the impact and acceptability of new HPV vaccine delivery strategies to improve vaccine coverage and effectiveness and reduce hesitancy. The consortium builds on previous successful collaborations in HPV epidemiology and vaccine research and qualitative research on barriers and facilitators to vaccine uptake. Tanzania has a multidose HPV vaccination programme in girls but will change to a single dose regimen in 2024. A gender-neutral HPV vaccination strategy is currently being implemented in Tanzania as part of a large cluster-randomised trial. Nigeria is one of the first countries to introduce national HPV vaccination with a single dose. Using these opportunities, IMPROVE-HPV will evaluate vaccine effectiveness, uptake and the factors affecting acceptability of (1) HPV two-dose vaccination delivery in females, (2) introducing or changing to a single dose vaccine regimen (3) gender-neutral HPV vaccination, and will also (4) investigate factors influencing vaccine hesitancy, community engagement and perceptions of HPV vaccines. The workplan directly addresses effectiveness and uptake of different HPV vaccine deployment strategies through phase IV/implementation research and will inform policy decision making in sub-Saharan Africa for HPV vaccination programmes.</objective>
  <title>Understanding vaccination hesitancy and evaluating single dose and gender-neutral vaccination for improving uptake of HPV vaccines in West and East Africa.</title>
  <totalCost>4130342.5</totalCost>
  <ecMaxContribution>3613287.5</ecMaxContribution>
  <startDate>2024-12-01</startDate>
  <endDate>2028-05-31</endDate>
  <ecSignatureDate>2024-11-29</ecSignatureDate>
  <duration>42</duration>
  <status>SIGNED</status>
  <keywords>gender-neutral,  single dose,  HPV,  uptake,  effectiveness,  hesitancy,  sub-Saharan Africa</keywords>
  <identifiers>
    <grantDoi>10.3030/101159996</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-05-19 07:26:02</sourceUpdateDate>
  <contentCreationDate>2024-12-12 10:55:09</contentCreationDate>
  <contentUpdateDate>2025-05-26 12:49:02</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:54</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56293</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2023-02-two-stage</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2023-02-two-stage</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56293</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2023-02-two-stage</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2023-02-two-stage</identifier>
      </call>
      <organization netEcContribution="1302056.25" totalCost="1490011.25" source="corda" order="3" ecContribution="1302056.25" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1907263</rcn>
        <id>997833084</id>
        <legalName>COLLEGE OF MEDICINE</legalName>
        <shortName>UNIVERSITY OF IBADAN UNIBADAN</shortName>
        <address>
          <street>QUEEN ELISABETH II ROAD</street>
          <city>IBADAN</city>
          <postalCode>2002012</postalCode>
          <country>NG</country>
          <postBox>PMB 5017</postBox>
          <url>http://www.comui.edu.ng</url>
          <geolocation>7.4012753,3.8964511</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Nigeria</name>
              <rcn>390236712</rcn>
              <nutsCode>NG</nutsCode>
              <euCode>NG</euCode>
              <isoCode>NG</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Nigeria</name>
              <rcn>390236712</rcn>
              <nutsCode>NG</nutsCode>
              <euCode>NG</euCode>
              <isoCode>NG</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="2059456.25" totalCost="2388556.25" source="corda" order="2" ecContribution="2059456.25" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1907272</rcn>
        <id>999495179</id>
        <legalName>NATIONAL INSTITUTE FOR MEDICAL RESEARCH</legalName>
        <shortName>NIMR</shortName>
        <address>
          <street>SOKOINE LUTHULI DRIVE OCEAN ROAD</street>
          <city>DAR ES SALAAM</city>
          <postalCode>255</postalCode>
          <country>TZ</country>
          <postBox>9653</postBox>
          <url>http://www.nimr.or.tz</url>
          <geolocation>-6.8142736,39.2803756</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Tanzania</name>
              <rcn>495880744</rcn>
              <nutsCode>TZ</nutsCode>
              <euCode>TZ</euCode>
              <isoCode>TZ</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Tanzania</name>
              <rcn>495880744</rcn>
              <nutsCode>TZ</nutsCode>
              <euCode>TZ</euCode>
              <isoCode>TZ</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="56600" totalCost="251775" source="corda" order="1" ecContribution="251775" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1911773</rcn>
        <id>998420031</id>
        <vatNumber>ESQ5856383D</vatNumber>
        <legalName>INSTITUT CATALA D'ONCOLOGIA</legalName>
        <shortName>ICO</shortName>
        <address>
          <street>AV GRAN VIA DE L'HOSPITALET 199-203</street>
          <city>Hospitalet de Llobregat</city>
          <postalCode>08908</postalCode>
          <country>ES</country>
          <url>http://www.iconcologia.net</url>
          <geolocation>41.3598601,2.0997927</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Barcelona</name>
              <rcn>242241601</rcn>
              <nutsCode>ES511</nutsCode>
              <parents>
                <region>
                  <name>Cataluña</name>
                  <rcn>242241640</rcn>
                  <nutsCode>ES51</nutsCode>
                  <parents>
                    <region>
                      <name>Este</name>
                      <rcn>242244136</rcn>
                      <nutsCode>ES5</nutsCode>
                      <parents>
                        <region>
                          <name>Spain</name>
                          <rcn>242387496</rcn>
                          <nutsCode>ES</nutsCode>
                          <euCode>ES</euCode>
                          <isoCode>ES</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Spain</name>
              <rcn>242387496</rcn>
              <nutsCode>ES</nutsCode>
              <euCode>ES</euCode>
              <isoCode>ES</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="0" totalCost="0" source="corda" order="4" terminated="false" sme="false" type="associatedPartner">
        <availableLanguages>en</availableLanguages>
        <rcn>1906028</rcn>
        <id>999912667</id>
        <vatNumber>GB233756066</vatNumber>
        <legalName>LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER</legalName>
        <shortName>LSHTM</shortName>
        <address>
          <street>KEPPEL STREET</street>
          <city>LONDON</city>
          <postalCode>WC1E 7HT</postalCode>
          <country>UK</country>
          <postBox>N/A</postBox>
          <url>http://www.lshtm.ac.uk/</url>
          <geolocation>51.5207316,-0.1294867</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Camden and City of London</name>
              <rcn>1465358</rcn>
              <nutsCode>UKI31</nutsCode>
              <parents>
                <region>
                  <name>Inner London — West</name>
                  <rcn>1465192</rcn>
                  <nutsCode>UKI3</nutsCode>
                  <parents>
                    <region>
                      <name>London</name>
                      <rcn>508635688</rcn>
                      <nutsCode>UKI</nutsCode>
                      <parents>
                        <region>
                          <name>United Kingdom</name>
                          <rcn>508725800</rcn>
                          <nutsCode>UK</nutsCode>
                          <euCode>UK</euCode>
                          <isoCode>GB</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>United Kingdom</name>
              <rcn>508725800</rcn>
              <nutsCode>UK</nutsCode>
              <euCode>UK</euCode>
              <isoCode>GB</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="195175" totalCost="0" source="corda" order="1" ecContribution="0" terminated="false" sme="false" type="thirdParty">
        <availableLanguages>en</availableLanguages>
        <rcn>1908679</rcn>
        <id>999600618</id>
        <vatNumber>ESG58863317</vatNumber>
        <legalName>FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE</legalName>
        <shortName>IDIBELL-CERCA</shortName>
        <address>
          <street>AVENIDA GRAN VIA HOSPITALET 199-203</street>
          <city>L'Hospitalet De Llobregat</city>
          <postalCode>08908</postalCode>
          <country>ES</country>
          <postBox>N/A</postBox>
          <url>http://www.idibell.cat</url>
          <geolocation>41.3598601,2.0997927</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Barcelona</name>
              <rcn>242241601</rcn>
              <nutsCode>ES511</nutsCode>
              <parents>
                <region>
                  <name>Cataluña</name>
                  <rcn>242241640</rcn>
                  <nutsCode>ES51</nutsCode>
                  <parents>
                    <region>
                      <name>Este</name>
                      <rcn>242244136</rcn>
                      <nutsCode>ES5</nutsCode>
                      <parents>
                        <region>
                          <name>Spain</name>
                          <rcn>242387496</rcn>
                          <nutsCode>ES</nutsCode>
                          <euCode>ES</euCode>
                          <isoCode>ES</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Spain</name>
              <rcn>242387496</rcn>
              <nutsCode>ES</nutsCode>
              <euCode>ES</euCode>
              <isoCode>ES</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705741</rcn>
        <id>HORIZON.2.1</id>
        <code>HORIZON.2.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1</pga>
        <title>Health</title>
        <parent>
          <programme>
            <rcn>705740</rcn>
            <code>HORIZON.2</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708305</rcn>
        <id>HORIZON_HORIZON-JU-GH-EDCTP3-2023-02-01-two-stage</id>
        <code>HORIZON-JU-GH-EDCTP3-2023-02-01-two-stage</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450332</code>
              <title>Clinical research</title>
              <displayCode>/Clinical research</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456393</code>
              <title>Public health</title>
              <displayCode>/Public health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458634</code>
              <title>Vaccines</title>
              <displayCode>/Vaccines</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453510</code>
              <title>Infectious diseases</title>
              <displayCode>/Infectious diseases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452784</code>
              <title>Global health</title>
              <displayCode>/Global health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450338</code>
              <title>Clinical trials</title>
              <displayCode>/Clinical trials</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/137/133</code>
        <title>epidemiology</title>
        <displayCode>/medical and health sciences/health sciences/public health/epidemiology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225/86801484</code>
        <title>cervical cancer</title>
        <displayCode>/medical and health sciences/clinical medicine/oncology/cervical cancer</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/77640482</code>
        <title>DNA viruses</title>
        <displayCode>/medical and health sciences/health sciences/infectious diseases/DNA viruses</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-JU-RIA</code>
        <title>HORIZON JU Research and Innovation Actions</title>
        <description>HORIZON JU Research and Innovation Actions</description>
        <displayCode>/HORIZON JU Research and Innovation Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>